| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cyteir Therapeutics Inc. Common Stock (NASDAQ: CYT)
CYT Technical Analysis
5
| As on 9th Jun 2023 CYT STOCK Price closed @ 2.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.66 & Strong Sell for SHORT-TERM with Stoploss of 7.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CYTSTOCK Price
| Open | 2.25 | Change | Price | % |
| High | 2.25 | 1 Day | 0.05 | 2.42 |
| Low | 2.09 | 1 Week | -0.09 | -4.07 |
| Close | 2.12 | 1 Month | -0.07 | -3.20 |
| Volume | 8401 | 1 Year | -7.78 | -78.59 |
| 52 Week High 11.37 | 52 Week Low 1.18 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CYT Daily Charts |
CYT Intraday Charts |
Whats New @ Bazaartrend |
CYT Free Analysis |
|
|
CYT Important Levels Intraday
| RESISTANCE | 2.43 |
| RESISTANCE | 2.33 |
| RESISTANCE | 2.27 |
| RESISTANCE | 2.21 |
| SUPPORT | 2.03 |
| SUPPORT | 1.97 |
| SUPPORT | 1.91 |
| SUPPORT | 1.81 |
CYT Forecast May 2024
| 4th UP Forecast | 11.2 |
| 3rd UP Forecast | 8.29 |
| 2nd UP Forecast | 6.49 |
| 1st UP Forecast | 4.69 |
| 1st DOWN Forecast | -0.45 |
| 2nd DOWN Forecast | -2.25 |
| 3rd DOWN Forecast | -4.05 |
| 4th DOWN Forecast | -6.96 |
CYT Weekly Forecast
| 4th UP Forecast | 5.95 |
| 3rd UP Forecast | 4.72 |
| 2nd UP Forecast | 3.96 |
| 1st UP Forecast | 3.20 |
| 1st DOWN Forecast | 1.04 |
| 2nd DOWN Forecast | 0.28 |
| 3rd DOWN Forecast | -0.48 |
| 4th DOWN Forecast | -1.71 |
CYT Forecast2024
| 4th UP Forecast | 22.51 |
| 3rd UP Forecast | 15.97 |
| 2nd UP Forecast | 11.93 |
| 1st UP Forecast | 7.89 |
| 1st DOWN Forecast | -3.65 |
| 2nd DOWN Forecast | -7.69 |
| 3rd DOWN Forecast | -11.73 |
| 4th DOWN Forecast | -18.27 |
Cyteir Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : CYT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CYT Business Profile
Cyteir Therapeutics, Inc. operates as a clinical-stage oncology company that develops novel therapeutics based on the biology of DNA repair for the treatment of cancer and synthetic lethality therapeutics for autoimmune diseases. The company engages in manufacturing therapeutics that provide precision targeting of key DNA repair factors to induce diseased cells to self-destruct by DNA damage overload and uses an integrated drug development platform that modulates the imbalance between DNA damage and repair for the therapeutic effect to deliver a pipeline of small molecule therapeutics with a range of potential disease state applications. It provides CYT-0851, an oral small-molecule inhibitor of RAD51-mediated DNA repair. It focuses on providing treatments for a range of hematological malignancies, solid tumors, and chronic autoimmune disorders. The company was incorporated in 2012 and is based in Lexington, Massachusetts. Address: 128 Spring Street, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service